Correction to “Unexpected Fatal Pneumocystis Jirovecii Pneumonia During Triplet Therapy for Hormone‐Sensitive Prostate Cancer”
Year: 2026
Type: erratum
Abstract: F. Ito, K. Kobayashi, G. Hayashi, S. Kamijo, T. Fujita, “Unexpected Fatal Pneumocystis Jirovecii Pneumonia During Triplet Therapy for Hormone-Sensitive Prostate Cancer,” Respirology Case Reports 13, no. 12 (2025): e70435, https://doi.org/10.1002/rcr2.70435. In this published article, the androgen deprivation therapy was incorrectly described as relugolix in the Abstract and the Case Presentation sections. In the Abstract section, the text “received triplet therapy with relugolix, darolutamide and docetaxel” was incorrect. It should read “received triplet therapy with degarelix, darolutamide and docetaxel”. In the Case Presentation section, the sentence “He began oral relugolix (ADT), followed by darolutamide and docetaxel” was incorrect. It should read “He began degarelix (ADT), followed by darolutamide and docetaxel”. We apologise for these errors.
Source: Respirology Case Reports
DOI: 10.1002/rcr2.70484
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,130
OpenAlex ID: W7127114940
Cites:
Cited by:
Related to: